Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | -153,473 | 74,150 | 34,727 | 286,342 | 13,971 |
| Operating Income | 153,473 | -74,150 | -34,727 | -286,342 | -13,971 |
| Other Income | 10,639 | -43,868 | 8,485 | -39,030 | -1,408 |
| Pre-tax Income | 164,112 | -118,018 | -26,242 | -325,372 | -15,379 |
| Net Income Continuous | 164,112 | -118,018 | -26,242 | -325,372 | -15,379 |
| Net Income | $164,112 | $-118,018 | $-26,242 | $-325,372 | $-15,379 |
| EPS Basic Total Ops | 304.00 | -227.87 | -97.93 | -630.22 | -7.91 |
| EPS Basic Continuous Ops | 303.91 | -227.83 | -98.37 | -629.93 | -7.97 |
| EPS Diluted Total Ops | 304.00 | -227.87 | -97.93 | -630.22 | -7.91 |
| EPS Diluted Continuous Ops | 303.91 | -227.83 | -98.37 | -629.93 | -7.97 |
| EPS Diluted Before Non-Recurring Items | -11.51 | -20.14 | -51.08 | N/A | N/A |
| EBITDA(a) | $153,497 | $-74,125 | $-34,703 | $-286,315 | $-13,948 |